↓ Skip to main content

Effect of Fagonia Arabica (Dhamasa) on in vitro thrombolysis

Overview of attention for article published in BMC Complementary Medicine and Therapies, November 2007
Altmetric Badge

Mentioned by

twitter
2 X users
facebook
1 Facebook page

Citations

dimensions_citation
99 Dimensions

Readers on

mendeley
151 Mendeley
Title
Effect of Fagonia Arabica (Dhamasa) on in vitro thrombolysis
Published in
BMC Complementary Medicine and Therapies, November 2007
DOI 10.1186/1472-6882-7-36
Pubmed ID
Authors

Sweta Prasad, Rajpal Singh Kashyap, Jayant Y Deopujari, Hemant J Purohit, Girdhar M Taori, Hatim F Daginawala

Abstract

Atherothrombotic diseases such as myocardial or cerebral infarction are serious consequences of the thrombus formed in blood vessels. Thrombolytic agents are used to dissolve the already formed clots in the blood vessels; however, these drugs have certain limitations which cause serious and sometimes fatal consequences. Herbal preparations have been used since ancient times for the treatment of several diseases. Herbs and their components possessing antithrombotic activity have been reported before; however, herbs that could be used for thrombolysis has not been reported so far. This study's aim was to investigate whether herbal preparations (aqueous extract) possess thrombolytic activity or not. An in vitro thrombolytic model was used to check the clot lysis effect of six aqueous herbal extracts viz., Tinospora cordifolia, Rubia cordifolia, Hemidesmus indicus, Glycyrrhiza glabra Linn, Fagonia Arabica and Bacopa monnieri Linn along with Streptokinase as a positive control and water as a negative control. Using an in vitro thrombolytic model, Tinospora cordifolia, Rubia cordifolia, Hemidesmus indicus, Glycyrrhiza glabra Linn, Fagonia Arabica and Bacopa monnieri Linn showed 19.3%, 14.5%, 20.3%, 17.8%, 75.6% and 41.8% clot lysis respectively . Among the herbs studied Fagonia arabica showed significant % of clot lysis (75.6%) with reference to Streptokinase (86.2%). Through our study it was found that Dhamasa possesses thrombolytic properties that could lyse blood clots in vitro; however, in vivo clot dissolving properties and active component(s) of Dhamasa for clot lysis are yet to be discovered. Once found Dhamasa could be incorporated as a thrombolytic agent for the improvement of patients suffering from Atherothrombotic diseases.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 151 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
India 3 2%
Japan 1 <1%
United States 1 <1%
Brazil 1 <1%
Unknown 145 96%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 29 19%
Student > Ph. D. Student 18 12%
Student > Master 17 11%
Researcher 12 8%
Student > Doctoral Student 5 3%
Other 22 15%
Unknown 48 32%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 28 19%
Agricultural and Biological Sciences 25 17%
Biochemistry, Genetics and Molecular Biology 16 11%
Medicine and Dentistry 11 7%
Chemistry 6 4%
Other 16 11%
Unknown 49 32%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 April 2024.
All research outputs
#16,190,925
of 25,845,749 outputs
Outputs from BMC Complementary Medicine and Therapies
#1,793
of 3,996 outputs
Outputs of similar age
#80,039
of 92,794 outputs
Outputs of similar age from BMC Complementary Medicine and Therapies
#8
of 11 outputs
Altmetric has tracked 25,845,749 research outputs across all sources so far. This one is in the 36th percentile – i.e., 36% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,996 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.7. This one has gotten more attention than average, scoring higher than 53% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 92,794 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 13th percentile – i.e., 13% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one is in the 27th percentile – i.e., 27% of its contemporaries scored the same or lower than it.